ScholarIQanswers from OpenAlex & ORCID
Victor Cohen
ResearcherPublications, citations & collaboration network
Victor Cohen is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Victor Cohen have?
ScholarIQindexed works
Victor Cohen has 135 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Victor Cohen have?
ScholarIQcitation count
Victor Cohen has 5,420 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Victor Cohen?
ScholarIQh-index
Victor Cohen has an h-index of 32 in OpenAlex.
What is the i10-index of Victor Cohen?
ScholarIQi10-index
Victor Cohen has an i10-index of 60 in OpenAlex.
What is the OpenAlex record for Victor Cohen?
ScholarIQopenalex
The OpenAlex for Victor Cohen is on the source record.
What are the most-cited papers on Victor Cohen?
ScholarIQmost cited works
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky, Timothy C. Tan, Victor Cohen, José Banchs, Joseph R. Carver, Susan E. Wiegers, Randolph P. Martin, Michael H. Picard, Robert E. Gerszten, Elkan F. Halpern, Jonathan Passeri, Irene Kuter, Marielle Scherrer‐Crosbie
Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
Heloisa Sawaya, Igal A. Sebag, Juan Carlos Plana, James L. Januzzi, Bonnie Ky, Victor Cohen, Sucheta Gosavi, Joseph R. Carver, Susan E. Wiegers, Randolph P. Martin, Michael H. Picard, Robert E. Gerszten, Elkan F. Halpern, Jonathan Passeri, Irene Kuter, Marielle Scherrer‐Crosbie
Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
Bonnie Ky, Mary Putt, Heloisa Sawaya, Benjamin French, James L. Januzzi, Igal A. Sebag, Juan Carlos Plana, Victor Cohen, José Banchs, Joseph R. Carver, Susan E. Wiegers, Randolph P. Martin, Michael H. Picard, Robert E. Gerszten, Elkan F. Halpern, Jonathan Passeri, Irene Kuter, Marielle Scherrer‐Crosbie
Systemic cancer therapy: achievements and challenges that lie ahead
Michael Palumbo, Petr Kavan, Wilson H. Miller, Lawrence Panasci, Sarit Assouline, Nathalie Johnson, Victor Cohen, François Patenaude, Michaël Pollak, R. Thomas Jagoe, Gerald Batist
Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti–PD-L1)
Marcin Kowanetz, Wei Zou, Scott Gettinger, Hartmut Koeppen, Mark Kockx, Peter Schmid, Edward E. Kadel, Ignacio I. Wistuba, Jamie E. Chaft, Naiyer A. Rizvi, David R. Spigel, Alexander I. Spira, Fred R. Hirsch, Victor Cohen, Dustin Smith, Zach Boyd, Natasha Miley, Susan Flynn, Vincent Lévêque, David S. Shames, Marcus Ballinger, Simonetta Mocci, Geetha Shankar, Roel Funke, Garret M. Hampton, Alan Sandler, Lukas C. Amler, Ira Mellman, Daniel S. Chen, Priti S. Hegde